Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

Exit

PublicNASDAQ:STXS
Date8/2004
Raised
Post IPO Valuation

General Information

Offices

St. Louis, USA
4320 Forest Park Avenue
Suite 100
St. Louis, MO, 63108
USA

People

founder, CEO and Chairman
Vice President of Sales and Marketing
Board of Directors
Board Chairman & Interim CEO

Funding

TOTAL $10M
FUNDING TOTAL $10M
Series A, 5/2012
$10M

Tags

Stereotaxis

Stereotaxis is a healthcare technology and innovation leader in the development of robotic cardiology instrument navigation systems designed to enhance the treatment of arrhythmias and coronary disease, as well as information management solutions for the interventional lab. With over 100 patents for use in a hospital’s interventional surgical suite, Stereotaxis helps physicians around the world provide unsurpassed patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced collaboration of life-saving information. Stereotaxis’ core technologies are the Niobe® ES Remote Magnetic Navigation system, the Odyssey™ portfolio of lab optimization, networking and patient information management systems and the Vdrive™ Robotic Mechanical Navigation system and consumables.

Recent Milestones

Videos

Screenshots

Stock Price

Sources

  1. SEC (sec.gov) [edit]
Edit This Page
Last Edited 2/22/14

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize »

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy